Keywords
How to Cite
Abstract
Chronic myeloproliferative syndromes are rare disorders in pediatric age, for which the knowledge of the pathology and its management is limited.
Chronic myeloproliferative syndromes in adults are commonly driven by JAK2 and MPL mutations, but in pediatrics there is no clear relationship.
Currently, there are guidelines and protocols for the management of adult patients, which allows risk stratification and recommended treatment. However, this would not be the case in pediatric patients.
We present a patient with essential thrombocythemia and the differential diagnoses that were studied at the Alejandro A. Posadas hospital.
References
2. Lundstrom U. Thrombocytosis in low birthweight infants: a physiological phenomenon in infancy. Arch Dis Child. 1979 Sep. 54(9):715-7.
3. Matsubara K, Fukaya T, Nigami H et al. Age-dependent changes in the incidence and etiology of childhood thrombocytosis. Acta Haematol. 2004. 111(3):132-7.
4. Mata Fernández C et al. Trombocitosis en la consulta de oncohematología. Descripción, diagnóstico etiológico y evolución. An Pediatr (Barc). 2008;69(1):10-4.
5. Badell M, Torrent E, López. Alteraciones plaquetarias: trombopenias y trombocitosis. An Pediatr Contin. 2006;4(1):24-30.
6. Schafer AI. Thrombocytosis and thrombocythemia. Blood Reviews. 2001;15:159-66.
7. Rivarola CM, Samudio-D GC. Trombocitosis en Pediatría: posibles causas en una población internada. Pediatr (Asunción). 2009;36:;1.
8. Dame C, Heinz A. Primary and secondary thrombocytosis in childhood. Br J Haematol. 2005; 129, 165–177.
9. Teofili L, Foa R, Giona F, Larocca LM. Childhood polycythemia vera and essential thrombocythemia: does their pathogenesis overlap with that of adult patients? Haematologica. 2008 Feb. 93(2):169-72.
10. Fu R, Zhang L, Yang R. Paediatric essential thrombocythaemia: clinical and molecular features, diagnosis and treatment. Br J Haematol. 2013 Nov. 163(3):295-302.
All material published in the journal HEMATOLOGÍA (electronic and print version) is transferred to the Argentinean Society of Hematology. In accordance with the copyright Act (Act 11 723), a copyright transfer form will be sent to the authors of approved works, which has to be signed by all the authors before its publication. Authors should keep a copy of the original since the journal is not responsible for damages or losses of the material that was submitted. Authors should send an electronic version to the email: revista@sah.org.ar